Guggenheim Initiates Coverage On Disc Medicine with Buy Rating, Announces Price Target of $132

Benzinga · 2d ago
Guggenheim analyst Debjit Chattopadhyay initiates coverage on Disc Medicine (NASDAQ:IRON) with a Buy rating and announces Price Target of $132.